Table of Contents
FDA Corner
| FDA Approves Novel Preventive Treatment for Migraine | Abstract PDF |
| 5 |
| FDA Approves First Drug Comprised of an Active Ingredient Derived From Marijuana to Treat Rare, Severe Forms of Epilepsy | Abstract PDF |
| 5-6 |
| FDA Approves First-of-its Kind Targeted RNA-based Therapy to Treat a Rare Disease | Abstract PDF |
| 6-8 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.